The rbcDNA Preparation Kit is Timing Biotech's innovative solution designed to isolate tumor-associated micronuclei DNA (taMN-DNA) from red blood cells (RBCs). By analyzing the abundance of taMN-DNA from micronuclei within RBCs and leveraging deep learning models, this kit offers highly accurate predictions of cancer risk. Unlike traditional blood-based early cancer detection technologies that rely on plasma, rbcDNA provides several distinct advantages:

Long-term stability: taMN-DNA is sourced from within RBCs, where it remains stable in the bloodstream for extended periods, avoiding the degradation issues commonly seen with plasma-based DNA.

No genomic DNA contamination: Since RBCs lack a nucleus, there is no risk of contamination from nuclear genomic DNA, ensuring cleaner and more precise results.

Minimal sample requirement: Thanks to the abundance and easy availability of red blood cells, only 2 milliliters of peripheral blood is needed to effectively detect taMN-DNA.